Brief: Knight Therapeutics Says As Of March 27, COVID-19 Outbreak Had No Material Impact On Co's Results
27/03/2020 23:28
March 27 (Reuters) - Knight Therapeutics Inc GUD.TO :
* KNIGHT THERAPEUTICS - HAS SUFFICIENT LIQUIDITY TO MEET ALL
OPERATING REQUIREMENTS FOR FORESEEABLE FUTURE
* KNIGHT THERAPEUTICS INC - AS OF MARCH 27, COVID-19
OUTBREAK HAS
NOT HAD A MATERIAL IMPACT ON CO'S RESULTS
Source text for Eikon: ID:nGNX7DNDz
Further company coverage: GUD.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Knight Therapeutics
See all newsBrief: Knight Therapeutics Announces Regulatory Approval Of Niktimvo In Brazil
Brief: Knight Therapeutics - Launches Tavalisse In Brazil For Chronic Immune Thrombocytopenia
Brief: Knight Therapeutics Enters Into Exclusive Distribution Agreement With Kyowa Kirin International For Poteligeo® (Mogamulizumab)
Brief: Knight Therapeutics Announces Regulatory Approval Of Tavalisse® In Colombia
Brief: Knight Therapeutics Announces Supplemental Regulatory Submission For Minjuvi In Brazil